Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00691600 · ClinicalTrials.gov registry record · Phase 3
Management of Skin and Soft Tissue Abscesses in Pediatric Patients After Incision and Drainage
A Phase 3 study of Abscess, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- Phase 3
- Development phase
- 23
- Enrollment target
- 1
- Study location
NCT00691600 is a Phase 3 study of Abscess that has completed, run by Baylor College of Medicine. The registered enrollment target is 23 participants, below the 388-participant average among 13 other Abscess trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00691600, a Phase 3 study of Abscess, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to compare rates of cure of abscesses with and without antibiotic treatment after incision and drainage. The purpose of this study is to compare successful rates of cure of abscesses less than 5 cm with antibiotic (oral TMP/SMX) versus non-antibiotic treatment after incision and drainage.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG oral trimethoprim/sulfamethoxazole
Study Locations (1)
Texas
- Texas Children's Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2007-12 |
| Est. Completion | 2010-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00691600
The ClinicalTrials.gov registry entry for NCT00691600 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 388-participant average among 13 other Abscess trials with a reported enrollment target (94% lower). The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Abscess appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00691600 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT00691600 about?
NCT00691600 is a clinical study titled "Management of Skin and Soft Tissue Abscesses in Pediatric Patients After Incision and Drainage". The purpose of the study is to compare rates of cure of abscesses with and without antibiotic treatment after incision and drainage. The purpose of this study is to compare successful rates of cure of abscesses less than 5 cm with antibiotic (oral TMP/SMX) versus non-antibiotic treatment after incis...
What is the current status of trial NCT00691600?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 23 participants. The study started on 2007-12. Estimated completion is 2010-04.
What conditions does trial NCT00691600 study?
This clinical trial studies the following conditions: Abscess.
What interventions are being tested in trial NCT00691600?
The interventions under investigation include: Placebo (DRUG), oral trimethoprim/sulfamethoxazole (DRUG).
Who is sponsoring clinical trial NCT00691600?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00691600 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Abscess
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Efficacy of Intranasal Fentanyl at Reducing Pain During Abscess Incision and Drainage (I&D) in Children
COMPLETED · Phase 3
-
Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infection
COMPLETED · Phase 3
-
Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections
COMPLETED · Phase 3
-
Incision and Drainage Versus Needle Aspiration in Soft Tissue Abscesses
COMPLETED · Phase 3
-
Oritavancin Versus IV Vancomycin for the Treatment of Participants With Acute Bacterial Skin and Skin Structure Infection (SOLO I)
COMPLETED · Phase 3
-
Intranasal Fentanyl as an Adjunct to Lidocaine Infiltration in Adults Undergoing Abscess Incision and Drainage
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.